Efficacy of sublingual immunotherapy with HDM mix extract (Der p and Der f) (SLITone) in pediatric patients with mild-to-moderate atopic eczema (AE) and sensitization to HDM (SPT positive).

Trial Profile

Efficacy of sublingual immunotherapy with HDM mix extract (Der p and Der f) (SLITone) in pediatric patients with mild-to-moderate atopic eczema (AE) and sensitization to HDM (SPT positive).

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2013

At a glance

  • Drugs House dust mite allergy immunotherapy-ALK Abello (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Aug 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 04 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top